Theres definitely equity issues. "The insurance companies are practicing blatant bias and stigma against people with obesity." Dr
Healthcare professionals should be aware that: Patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should be carefully evaluated before prescribing Routine calcitonin measurement is not recommended for patients without risk factors, as per UK guidance [23] [24] Patients should be counselled about symptoms of thyroid tumours, including a neck mass, dysphagia, dyspnoea, or persistent hoarseness The theoretical risk must be balanced against the proven cardiovascular and metabolic benefits of these medicines in appropriate patient populations
Monitor urine color (pale yellow = adequate hydration) and consider electrolyte supplements to prevent weakness or fatigue
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance
In February 2026, less than a year after its own drug was dropped, Pfizer announced that the long-acting GLP-1 drug it is now working on was progressing as hoped
In TNBC xenograft models and basal-like breast cancer, CB-839, either alone or in combination with paclitaxel, exhibits a potent antitumor effect (Gross et al., 2014)